#LatinasInMedicine
@LatinasInMed
A supporting community empowering Latinas in all health professions. Managed by @NarjustFlorezMD @BriChristophers @MoraPinzonMD @CeliaMarAceves @ClaudiaCastZ
The #LatinasInMedicine store is now OPEN! 🎉💃 T-shirts, water bottles, fanny packs, totes, AND MORE available at latinasinmedicine.myspreadshop.com Be sure to tag @LatinasInMed when your items arrive, so we can see you celebrating for #LatinxHeritageMonth!
We'll be live within the next 15 minutes for our #BTGLung2025 livestream with @NarjustFlorezMD, @DrEdKim, and @lungoncdoc discussing the results of the community polling questions! See you soon! #lcsm #oncology
🫁 Support Team Lung Cancer! Donate and walk with us in the #JimmyFundWalk on Oct 5 to fight lung cancer - the deadliest cancer in the U.S. Funds go to the Young Lung Cancer Program + Thoracic Oncology at @DanaFarber ➡️ danafarber.jimmyfund.org/site/TR?team_i… #LungCancerAwareness
LIVE from 2025 Bridging the Gaps in Lung Cancer as we discuss 2nd L therapy for EGFR positive NSCLC #BTGLung2025 @OncLive @lungoncdoc @DrEdKim
Day two of #BTGLung2025 Dr. @christinemphmd discusses treatment advances in ROS1 and MET altered lung cancers. Key area with recent approvals and many questions regarding biomarker testing particularly for MET altered NSCLC #LCSM @NarjustFlorezMD @DrEdKim @OncLive
The Day I Became a Zebra” - a powerful new piece by @NarjustFlorezMD From physician to patient. From being dismissed as “anxious” to facing a rare diagnosis. Read her story on medical bias, resilience, & rare disease 🔗 incrowdnow.com/resources/the-… #ZebraStrong #RareDisease
🕊️ We mourn the loss of Dr. Samantha Garza (1996–2025). She was a proud member of our Latinas in Medicine community. Diagnosed with a brain tumor in med school, Sam met every challenge with grace and earned her MD. She served others even in illness, and her legacy lives on.

From our most recent publication Clinical characteristics of young lung cancer (understanding that each patient is unique) frontiersin.org/journals/oncol…
🚨 Bottom Line: Young adults do get lung cancer. They are: 🧬 Molecularly distinct 🩺 Clinically unique 🧠 Psychosocially burdened 🏥 Often overlooked We must improve awareness, screening, diagnostics & care. Read our full review 👉 frontiersin.org/articles/10.33… #YoungLungCancer
💸 The hidden burdens: 🔹 Fertility concerns 🔹 Financial toxicity 🔹 Psychosocial distress 🔹 End-of-life planning Young patients face life-altering diagnoses during formative years. We need care models that reflect this. #LungCancer #YoungAdults #CancerEquity
Engaging in Multi-Disciplinary Discussions at the São Paulo Oncology Conference - @NarjustFlorezMD oncodaily.com/blog/321819 #OncoDaily #Oncology #Cancer #Health #Medicine #MedX
A fantastic team effort and the first publication from our @DFarberThoracic dedicated Young Lung Cancer Clinical and Research Program. From diagnosis to survivorship: Young Lung Cancer We worked on building this program and are honored by the trust of our colleagues across…
📣 NEW PUBLICATION ‼️ Young adults do get lung cancer -and they face distinct challenges. Our latest review, "Young lung cancer: from diagnosis to survivorship," is now published! Read here 👉 frontiersin.org/articles/10.33… #YoungLungCancer #CancerCare #OncoTwitter #FlorezLab
📣 NEW PUBLICATION ‼️ Young adults do get lung cancer -and they face distinct challenges. Our latest review, "Young lung cancer: from diagnosis to survivorship," is now published! Read here 👉 frontiersin.org/articles/10.33… #YoungLungCancer #CancerCare #OncoTwitter #FlorezLab
📢 In a new article published by @uicc , @NarjustFlorezMD discusses the hidden epidemic of lung cancer in women especially never-smokers and the urgent need for gender-responsive, equitable care. 📖 Read: uicc.org/news-and-updat… #LungCancer #FlorezLab
With #ASCOszn almost here we are curious to know Since the start of your oncology career, approximately what percentage of @ASCO Annual Meetings have you attended? #conferenceattendance #classinsession
🚨Hello friends and colleagues! I’m preparing a presentation and would love your input. 🙏 Please respond to the poll below: ❔Since the start of your oncology career, approximately what percentage of @ASCO Annual Meetings have you attended?😊 #ASCO25 @OncoAlert @ASCOTECAG…
@YoungLungCancer @EGFRResisters @ALKPositiveinc @OncogeneCancer @oncodaily @RETpositive @DanaFarber_CGCM @DFarberThoracic @DanaFarberYAP @DFEGFRcenter @DanaFarberNews @DanaFarber @AWforHealth @LatinasInMed